- Release Date: 14/07/23 08:18
- Summary: Kal East 302koz Study Update
- Price Sensitive: Yes
- Download Document 7.46MB
- Forums
- ASX - By Stock
- BC8
- Ann: Kal East 302koz Study Update
Ann: Kal East 302koz Study Update
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BC8 (ASX) to my watchlist
(20min delay)
|
|||||
Last
41.0¢ |
Change
0.025(6.49%) |
Mkt cap ! $181.8M |
Open | High | Low | Value | Volume |
38.5¢ | 41.5¢ | 38.0¢ | $1.361M | 3.424M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 19846 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
41.5¢ | 33830 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 19846 | 0.410 |
1 | 178006 | 0.405 |
1 | 9000 | 0.400 |
1 | 45000 | 0.385 |
2 | 21917 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.415 | 33830 | 2 |
0.420 | 207426 | 5 |
0.425 | 100000 | 1 |
0.430 | 59000 | 1 |
0.440 | 128104 | 4 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
BC8 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online